Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.96B | 1.48B | 1.27B | 1.27B | 816.53M |
Gross Profit | 1.23B | 920.71M | 785.69M | 826.65M | 575.05M |
EBITDA | 77.34M | 154.39M | 318.65M | 372.47M | 224.51M |
Net Income | 88.42M | 53.48M | 213.78M | 285.85M | 150.69M |
Balance Sheet | |||||
Total Assets | 4.95B | 4.76B | 4.49B | 4.14B | 1.21B |
Cash, Cash Equivalents and Short-Term Investments | 3.19B | 3.44B | 3.65B | 3.63B | 877.58M |
Total Debt | 14.48M | 65.28M | 28.20M | 30.29M | 14.17M |
Total Liabilities | 1.44B | 1.35B | 884.01M | 826.11M | 712.47M |
Stockholders Equity | 3.46B | 3.34B | 3.61B | 3.32B | 501.70M |
Cash Flow | |||||
Free Cash Flow | -76.78M | 51.28M | 51.48M | 241.95M | 366.61M |
Operating Cash Flow | 123.48M | 165.87M | 146.87M | 441.71M | 408.28M |
Investing Cash Flow | -1.01B | -981.71M | -159.77M | -182.05M | -7.28M |
Financing Cash Flow | -207.73M | -187.06M | -193.61M | 2.52B | -23.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | €10.22B | 16.13 | 18.36% | 3.02% | 7.13% | 13.39% | |
76 Outperform | $31.07B | 13.92 | 8.95% | 3.37% | -3.09% | 0.67% | |
75 Outperform | HK$19.44B | 33.63 | 24.57% | 0.73% | 13.58% | 24.59% | |
74 Outperform | €4.33B | 10.70 | 15.04% | 3.07% | 6.05% | 1.32% | |
73 Outperform | HK$5.72B | 25.69 | 11.24% | 0.92% | 11.23% | 20.39% | |
64 Neutral | HK$11.28B | 241.07 | 1.33% | 0.66% | ― | ― | |
60 Neutral | HK$18.32B | 5.45 | -4.00% | 3.31% | 9.92% | -18.97% |
Angelalign Technology Inc. has announced a board meeting scheduled for August 25, 2025, to discuss and approve the unaudited interim results for the first half of the year ending June 30, 2025. The meeting will also consider the potential payment of an interim dividend, which could impact stakeholders and reflect the company’s financial health.
The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.
Angelalign Technology Inc. has announced a significant increase in its projected net profit for the first half of 2025, expecting a rise of approximately 538.1% to 604.8% compared to the same period in 2024. This growth is attributed to strategic pricing adjustments in China, a delay in setting up non-China manufacturing facilities, and a low profit base from the previous year. The company is also focusing on expanding its global presence and supply chain resilience, despite regulatory uncertainties in China and potential tariff challenges in Brazil.
The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.
Angelalign Technology Inc. has announced the composition of its board of directors and the establishment of key committees, including the Audit, Remuneration, and Nomination Committees. This strategic move is aimed at strengthening the company’s governance structure and enhancing its operational efficiency, potentially impacting its market positioning and stakeholder relations positively.
The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.
Angelalign Technology Inc. has announced that its subsidiary, Wuxi EA, has entered into a Product Purchase Cooperation Framework Agreement with Shanghai Kaihao, a company associated with a substantial shareholder of Angelalign. This agreement involves the purchase of raw materials for the production of clear aligners over an 18-month period, with set annual caps for purchases. The transactions are classified as continuing connected transactions under Hong Kong’s Listing Rules, requiring reporting and annual review but exempt from independent shareholder approval. This strategic move is expected to secure essential materials for Angelalign’s production, potentially enhancing its market position in the orthodontic industry.
The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.
Angelalign Technology Inc. has announced the grant of 736,920 restricted share units (RSUs) to 231 employees under its post-IPO RSU scheme, aimed at providing long-term motivation. The RSUs will vest in four tranches over four years, with performance targets and a clawback mechanism in place. This initiative is part of the company’s strategy to offer competitive remuneration and align employee incentives with company performance, potentially strengthening its market position and stakeholder confidence.
The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.
Angelalign Technology Inc. has announced the amendment and restatement of the terms of reference for its Nomination Committee, effective from June 24, 2025. This move is part of the company’s ongoing efforts to enhance corporate governance and ensure a diverse and independent board structure, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:6699) stock is a Buy with a HK$84.95 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.
Angelalign Technology Inc. announced the results of its Annual General Meeting held on May 23, 2025, where all proposed resolutions were passed with significant shareholder support. Key resolutions included the approval of financial statements, granting of mandates for share issuance and buybacks, re-election of directors, re-appointment of auditors, and the declaration of a special final dividend. The successful passing of these resolutions indicates strong shareholder confidence and positions the company for continued strategic growth and operational stability.
The most recent analyst rating on (HK:6699) stock is a Buy with a HK$84.95 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.
Angelalign Technology Inc. announced the resignation of Mr. Zhu Lingbo from his roles as senior vice president, board secretary, company secretary, and authorized representative, effective May 15, 2025. Mr. Zhu’s resignation is amicable, with no disagreements reported. In his place, Mr. Lee Leong Yin has been appointed as the new company secretary and authorized representative. Mr. Lee, nominated by Tricor Services Limited, brings over 14 years of experience in corporate secretarial services and holds relevant professional qualifications. This change in leadership is expected to maintain the company’s compliance with listing rules and support its corporate governance framework.
The most recent analyst rating on (HK:6699) stock is a Buy with a HK$86.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.